Article History
Accepted: 13 April 2023
First Online: 25 May 2023
Competing interests
: J.T.G. has consulted for AbbVie, Bristol Myers Squibb, Eli Lilly, Gilead, Novartis, Pfizer and UCB. J.T.G. served as a co-author on secondary analyses for studies from the ORAL Surveillance study for which he received no compensation. B.N.W. has consulted for Horizon Therapeutics, Kinisika and NovoNordisk. K.P.L. declares no competing interests.